Increased use of antimicrobial agents and hospital admission for infections in patients with primary adrenal insufficiency: A cohort study

European Journal of Endocrinology

Volumn 168, Issue 4, 2013, Pages 609-614

  Smans, Lisanne C C J ^a   Souverein, Patrick C ^b   Leufkens, Hubert G M ^b   Hoepelman, Andy I M ^a   Zelissen, Pierre M J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CORTISONE ACETATE; FLUDROCORTISONE; GLUCOCORTICOID; HYDROCORTISONE; MINERALOCORTICOID; PREDNISONE;

ADRENAL INSUFFICIENCY; ADULT; AGED; ARTICLE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DATA BASE; DEMOGRAPHY; DRUG USE; FEMALE; HOSPITAL ADMISSION; HUMAN; INCIDENCE; INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MEDICAL RECORD; PATIENT INFORMATION; PRIORITY JOURNAL;

ADDISON DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; COHORT STUDIES; COMMUNICABLE DISEASES; DATABASES, FACTUAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT ADMISSION; YOUNG ADULT;

EID: 84875164126     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-12-0879     Document Type: Article

References (15)

1. Lovas K & Husebye ES. High prevalence and increasing incidence of Addison's disease in western Norway. Clinical Endocrinology 2002 56 787-791. (doi:10.1046/j.1365-2265.2002.t01-1-01552.x)
2. Bensing S, Brandt L, Tabaroj F, Sjöberg O, Nilsson B, Ekbom A, Blomqvist P & Kämpe O. Increased death risk and altered cancer incidence pattern in patients with isolated or combined autoimmune primary adrenocortical insufficiency. Clinical Endocrinology 2008 69 697-704. (doi:10.1111/j.1365-2265.2008.03340.x)
3. Erichsen MM, Løvås K, Fougner KJ, Svartberg J, Hauge ER, Bollerslev J, Berg JP, Mella B & Husebye ES. Normal overall mortality rate in Addison's disease, but young patients are at risk of premature death. European Journal of Endocrinology 2009 160 233-237. (doi:10.1530/EJE-08-0550)
4. Bergthorsdottir R, Leonsson-Zachrisson M, Oden A & Johannsson G. Premature mortality in patients with Addison's disease: a population-based study. Journal of Clinical Endocrinology and Metabolism 2006 91 4849-4853. (doi:10.1210/jc.2006-0076)
5. Herings RM, Bakker A, Stricker BH & Nap G. Pharmaco-morbidity linkage: a feasible study comparing morbidity in two pharmacy based exposure cohorts. Journal of Epidemiology and Community Health 1992 46 136-140. (doi:10.1136/jech.46.2.136)
6. Zelissen PMJ. Addison patients in the Netherlands, The Hague: Dutch Addison Society, 1994.
7. Rhen T & Cidlowski J. Antiinflammatory action of glucocorticoids, new mechanisms for old drugs. New England Journal of Medicine 2005 353 1711-1723. (doi:10.1056/NEJMra050541)
8. Heasman S, Giles K, Ward C, Rossi A, Haslett C & Dransfield I. Glucocorticoid mediated regulation of granulocyte apoptosis and macrophage phagocytosis of apoptotic cells: implications for the resolution of inflammation. Journal of Endocrinology 2003 178 29-36. (doi:10.1677/joe.0. 1780029)
9. Stuck A, Minder C & Frey F. Risk of infectious complications in patients taking glucocorticoids. Reviews of Infectious Disease 1989 11 954-963. (doi:10.1093/clinids/11.6.954)
10. Muller LM, Gorter KJ, Hak E, Goudzwaard WL, Schellevis FG, Hoepelman AI & Rutten GE. Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clinical Infectious Disease 2005 41 281-288. (doi:10.1086/431587)
11. Geerlings SE & Hoepelman AIM. Immune dysfunction in patients with diabetes mellitus. FEMS Immunology and Medical Microbiology 1999 26 259-265. (doi:10.1111/j.1574-695X.1999.tb01397.x)
12. Svec F & Porter Jr. The actions of exogenous dehydroepiandrosterone in experimental animals and humans. Proceedings of the Society for Experimental Biology and Medicine 1998 218 174-191.
13. Peleg AY, Weerarathna T, McCarthy JS & Davis TME. Common infections in diabetes: pathogenesis, management and relationship to glycaemic control. Diabetes/Metabolism Research and Reviews 2007 23 3-13. (doi:10.1002/dmrr.682)
14. Speiser PW, Azziz R, Baskin LS, Ghizzoni L, Hensle TW, Merke DP, Meyer-Bahlburg HFL, Miller WL, Montori VM, Oberfield SE et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an endocrine society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism 2010 95 4133-4160. (doi:10.1210/jc.2009-2631)
15. Sande-Bruinsma van de N, Grundmann H, Verloo D, Tiemersma E, Monen J, Goossens H & Ferech M. Antimicrobial drug use and resistance in Europe. Emerging Infectious Diseases 2008 14 1722-1730. (doi:10.3201/eid1411.070467)